1. Pui C-H, Ribeiro R, Hancock ML, Rivera GK, Evans WE, Raimondi S, Head DR, Behm FG, Mahmoud MH, Sandlund JT, Crist WM . Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphocytic leukemia New Engl J Med 1991 325: 1682–1687
2. Pui C-H, Relling MV, Rivera GK, Hancock ML, Raimondi SC, Heslop HE, Santana VM, Ribeiro RC, Sandlund JT, Mahmoud HH, Evans WE, Crist WM, Krance RA . Epipodophyllotoxin-related acute myeloid leukemia: a study of 35 cases Leukemia 1995 9: 1990–1996
3. Smith MA, Rubinstein L, Ungerleider RS . Therapy-related acute myeloid leukemia following treatment with epipodophyllotoxins: estimating the risks Med Pediatr Oncol 1995 23: 86–98
4. Felix CA . Secondary leukemias induced by topoisomerase-targeted drugs Biochim Biophys Acta 1998 1400: 233–255
5. Pedersen-Bjergaard J, Philip P, Larsen SO, Andersson M, Daugaard G, Ersboll J, Hansen SW, Hou-Jensen K, Nielsen D, Sigsgaard TC, Spect L, terlind K . Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series Leukemia 1993 7: 1975–1986